Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clopidogrel as prophylactic treatment for migraine.

Trial Profile

Clopidogrel as prophylactic treatment for migraine.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Nov 2018

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Therapeutic Use
  • Acronyms ClopMig
  • Most Recent Events

    • 05 Apr 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 28 Mar 2013 Accrual to date is 85% according to United Kingdom Clinical Research Network record.
    • 22 Oct 2011 United Kingdom Clinical Research Network reports accrual to date changed from 24% to 69%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top